F. Courbon

2.3k total citations
84 papers, 1.4k citations indexed

About

F. Courbon is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Epidemiology. According to data from OpenAlex, F. Courbon has authored 84 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Radiology, Nuclear Medicine and Imaging, 29 papers in Oncology and 24 papers in Epidemiology. Recurrent topics in F. Courbon's work include Medical Imaging Techniques and Applications (24 papers), Neuroendocrine Tumor Research Advances (21 papers) and Neuroblastoma Research and Treatments (19 papers). F. Courbon is often cited by papers focused on Medical Imaging Techniques and Applications (24 papers), Neuroendocrine Tumor Research Advances (21 papers) and Neuroblastoma Research and Treatments (19 papers). F. Courbon collaborates with scholars based in France, United Kingdom and United States. F. Courbon's co-authors include Philippe Rochaix, Slimane Zerdoud, Philippe Caron, I. Berry, Delphine Vezzosi, Christiane Susini, Jean‐Louis Montastruc, Christine Brefel‐Courbon, Olivier Rascol and Claire Thalamas and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

F. Courbon

79 papers receiving 1.4k citations

Peers

Countries citing papers authored by F. Courbon

Since Specialization

Citations

This map shows the geographic impact of F. Courbon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Courbon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Courbon more than expected).

Fields of papers citing papers by F. Courbon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Courbon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Courbon. The network helps show where F. Courbon may publish in the future.

Co-authorship network of co-authors of F. Courbon

This figure shows the co-authorship network connecting the top 25 collaborators of F. Courbon. A scholar is included among the top collaborators of F. Courbon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Courbon. F. Courbon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of a blood miRNA/mRNA signature to follow-up Lu-PRRT therapy for G1/G2 intestinal neuroendocrine tumors 2024 ·Frontiers in Endocrinology ·(unknown), Lawrence Dierickx, (unknown), (unknown), F. Courbon, Rosine Guimbaud, (unknown), (unknown)	2
2	Impact of different models based on blood samples and images for bone marrow dosimetry after 177Lu-labeled somatostatin-receptor therapy 2024 ·EJNMMI Physics ·(unknown), (unknown), (unknown), (unknown), (unknown), Lawrence Dierickx, F. Courbon	2
3	An extended bore length solid-state digital-BGO PET/CT system: design, preliminary experience, and performance characteristics 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·John A. Kennedy, (unknown), (unknown), (unknown), F. Courbon, (unknown), Zohar Keidar	7
4	PET-MRI for evaluation of response to radiochemotherapy in patients with locally advanced cervical cancer 2023 ·International Journal of Gynecological Cancer ·Ariane Weyl, Charlotte Chollet, (unknown), (unknown), (unknown), Alejandra Martínez, F. Courbon, Pierre Lèguevaque, (unknown), (unknown), Éric Lambaudie, Élodie Chantalat, Stéphanie Motton	3
5	Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study 2022 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Shaunak Navalkissoor, Rajaventhan Srirajaskanthan, F. Courbon, Lawrence Dierickx, (unknown), Valerie Lewington, Mercedes Mitjavila, Juan Carlos Percovich, (unknown), (unknown), (unknown), John Ramage	14
6	Tissue-inspired phantoms: a new range of equivalent tissue simulating breast, cortical bone and lung tissue 2018 ·Biomedical Physics & Engineering Express ·(unknown), (unknown), Marina Fiallo, Patrick Sharrock, (unknown), F. Courbon, (unknown)	5
7	Evaluation of the Interaction of Amino Acid Infusion on 177Lu-Dotatate Pharmacokinetics in Patients with Gastroenteropancreatic Neuroendocrine Tumors 2018 ·Clinical Pharmacokinetics ·Alicja Puszkiel, (unknown), (unknown), Lawrence Dierickx, F. Courbon, Étienne Chatelut	10
8	18F-fluorocholine PET/CT in patients with occult biochemical recurrence of prostate cancer: Detection rate, impact on management and adequacy of impact. A prospective multicentre study 2018 ·PLoS ONE ·(unknown), Virginie Huchet, Caroline Rousseau, Alexandre Cochet, Philippe Olivier, F. Courbon, É. Gontier, V. Nataf, Soňa Balogová, Jean‐Noël Talbot, (unknown)	14
9	Clinical outcomes 1 year after empiric 131I therapy for hyperthyroid disorders 2017 ·Nuclear Medicine Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), Slimane Zerdoud, D. Bastié, (unknown), Philippe Caron, Manuel Bardiès, F. Courbon	15
10	Controversies and consensus in the innovation access for cancer therapy in the European countries: on the subject of metastatic prostate cancer 2016 ·Annals of Oncology ·Stéphane Oudard, F. Courbon	1
11	Comparison of an alternative and existing binning methods to reduce the acquisition duration of 4D PET/CT 2014 ·Medical Physics ·(unknown), Cyril Jaudet, (unknown), Hadj Batatia, Lawrence Dierickx, Slimane Zerdoud, (unknown), (unknown), F. Courbon, (unknown)	3
12	Nonsurgical giant cell tumour of the tendon sheath or of the diffuse type: Are MRI or 18F-FDG PET/CT able to provide an accurate prediction of long-term outcome? 2014 ·European Journal of Nuclear Medicine and Molecular Imaging ·Laurent Dercle, Roland Chisin, Samy Ammari, (unknown), M. Ouali, Cyril Jaudet, Jean‐Pierre Delord, Lawrence Dierickx, Slimane Zerdoud, Martin Schlumberger, F. Courbon	16
13	Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands 2011 ·Chemistry and Physics of Lipids ·Philippe de Médina, Michaël R. Paillasse, Grégory Segala, Farid Khallouki, (unknown), Florence Dalenc, F. Courbon, Michel Record, Marc Poirot, Sandrine Silvente‐Poirot	48
14	Preclinical and Clinical Evidence that Deoxy-2-[18F]fluoro- D -glucose Positron Emission Tomography with Computed Tomography Is a Reliable Tool for the Detection of Early Molecular Responses to Erlotinib in Head and Neck Cancer 2010 ·Clinical Cancer Research ·S. Vergèz, Jean‐Pierre Delord, Fabienne Thomas, Philippe Rochaix, (unknown), Thomas Filleron, (unknown), Pierre Canal, F. Courbon, Ben Allal	20
15	Trastuzumab induced in vivo tissue remodelling associated in vitro with inhibition of the active forms of AKT and PTEN and RhoB induction in an ovarian carcinoma model 2010 ·British Journal of Cancer ·J.P. Delord, Stéphane Quideau, Philippe Rochaix, (unknown), Bettina Couderc, Isabelle Hennebelle, F. Courbon, Pierre Canal, Ben Allal	11
16	Adenoid cystic carcinoma of the lung: Interest of 18FDG PET/CT in the management of an atypical presentation 2007 ·Lung Cancer ·(unknown), Isabelle Rouquette, F. Courbon, V. Chabbert, Philippe Rochaix, Grégoire Prévôt, Sophie Laroumagne, L. Têtu, A. Didier, Julien Mazières	11
17	[Recommendation for clinical practice: use of PET-FDG in cancer of the kidney, prostate, testicles, and the urinary bladder]. 2006 ·PubMed ·P. Bourguet, François Planchamp, Françoise Montravers, S. Vincendeau, F. Courbon, Véronique Edeline, (unknown), Dominique Rossi, Arnauld Villers	5
18	Bulletin de synthèse de veille 2006 Recommandations pour la pratique clinique : utilisation de la TEP-FDG dans les cancers du rein, de la prostate, du testicule et de la vessie 2006 ·Bulletin du Cancer ·P. Bourguet, François Planchamp, Françoise Montravers, S. Vincendeau, F. Courbon, Véronique Edeline, (unknown), Dominique Rossi, Arnauld Villers	4
19	Preparation and Use of ¹³¹ I Magic Gel as a Dosimeter for Targeted Radionuclide Therapy 2006 ·Cancer Biotherapy and Radiopharmaceuticals ·F. Courbon, (unknown), Sarah Chittenden, Glenn Flux, Patrice Ravel, Gary Cook	11
20	Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: a randomized phase II trial 2001 ·British Journal of Cancer ·Alain Ravaud, M. Delaunay, Christine Chevreau, Vincent Coulon, Marc Debled, (unknown), F. Courbon, N. Gualde, (unknown)	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact